Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

72 evidence items · page 3 / 3

100 %RH5 antigen expression was predicted in 100.0% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

8.34 %Au Cameroun, le taux de prévalence de la drépanocytose est de 8,34 % dans la population générale.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

1 patientRH32 low-frequency antigen is predicted in one patient.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

5.9 %Among 413 Cameroonian patients with sickle cell disease, 5.9% had renal failure.

Cameroundrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 5 observations

32.1 %Among 218 alleles from Cameroonian patients with sickle cell disease (SCD), the c.733C>G SNV was found in 70/218 (32.1%) alleles.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

3 patientsRH54 (DAK) low-frequency antigen is predicted in three patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

17.4 %RH3 antigen expression was predicted in 17.4% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

3 samplesAmong 109 Cameroonian patients with sickle cell disease (SCD), three samples carried two RHD-negative alleles, in agreement with the D-negative phenotype observed by routine serologic testing.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

2 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à 2 hospitalisations par mois chez les adultes.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

1 %In Cameroon, the prevalence of sickle cell disease is ∼1% at birth.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

32.1 %The c.733C>G SNV was found in 70/218 (32.1%) alleles among Cameroonian patients with sickle cell disease (SCD).

Cameroundrépanocytoseobserved 2023HAL · Unilimdocument of 45 observations

87.7 %The most prevalent RHCE allelic background among Cameroonian patients with sickle cell disease (SCD) was RHCE*01 (*ce), found in 189 out of 216 total alleles (87.7%).

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

2 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à 2 par mois chez les adultes.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

71 %Among 413 Cameroonian patients with sickle cell disease, 71% had glomerular hyperfiltration.

Cameroundrépanocytosepublished 2021Frontiers in geneticseurope_pmcdocument of 5 observations

65 patients65 patients with sickle cell disease were potentially exposed to a total of ten undesirable RH antigens.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

5 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 5 et 7 par mois chez les adolescents.

CameroundrépanocytoseHAL · Unilimdocument of 75 observations

18.3 %RH2 antigen expression was predicted in 18.3% of the subset of patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

97.6 %Concordance between RH phenotype prediction and serologic testing was 97.6% for the five major RH antigens.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

The prevalence of dyspnea and congestive heart failure was low and did not differ significantly between sickle cell disease patients and healthy controls in Cameroon, Mali, and Senegal.

Cameroun · Mali · Sénégaldrépanocytosepublished 2018Frontiers in MedicineOpenAlexdocument of 10 observationsDOI 10.3389/fmed.2018.00323

30.3 %33 patients (30.3%) were not at risk of being exposed to undesirable RH antigen(s).

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

4.6 %The RHCE*02 (*Ce) allelic background was found in 10 out of 216 total alleles (4.6%) among Cameroonian patients with sickle cell disease (SCD).

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

13 patientsPartial RH4 antigen may be expected in 13 patients.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.